Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 54

1.

Comparison of bone tissue trace-element concentrations and mineral density in osteoporotic femoral neck fractures and osteoarthritis.

Karaaslan F, Mutlu M, Mermerkaya MU, Karaoğlu S, Saçmaci Ş, Kartal Ş.

Clin Interv Aging. 2014 Aug 18;9:1375-82. doi: 10.2147/CIA.S66354. eCollection 2014.

PMID:
25170261
[PubMed - in process]
Free PMC Article
2.

Distribution of magnesium, calcium, sodium and potassium in tissues of the hip joint.

Brodziak-Dopierała B, Kwapuliński J, Sobczyk K, Wiechuła D.

Magnes Res. 2013 Jul-Sep;26(3):125-31. doi: 10.1684/mrh.2013.0348.

PMID:
24153328
[PubMed - indexed for MEDLINE]
3.

Vitamin D: role and opportunity to prescribe.

Resmini G, Tarantino U, Iolascon G.

Aging Clin Exp Res. 2013 Oct;25 Suppl 1:S125-7. doi: 10.1007/s40520-013-0108-8. Epub 2013 Sep 18.

PMID:
24046033
[PubMed - indexed for MEDLINE]
4.

Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data.

Abrahamsen B, Vestergaard P.

Bone. 2013 Nov;57(1):269-71. doi: 10.1016/j.bone.2013.08.013. Epub 2013 Aug 22.

PMID:
23973557
[PubMed - indexed for MEDLINE]
5.

Vitamin D interactions with soy isoflavones on bone after menopause: a review.

Park CY, Weaver CM.

Nutrients. 2012 Nov 6;4(11):1610-21. doi: 10.3390/nu4111610. Review.

PMID:
23201836
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

What is the optimal dietary intake of vitamin D for reducing fracture risk?

Dawson-Hughes B.

Calcif Tissue Int. 2013 Feb;92(2):184-90. doi: 10.1007/s00223-012-9606-5. Epub 2012 May 17. Review.

PMID:
22592290
[PubMed - indexed for MEDLINE]
7.

Protein intake, calcium balance and health consequences.

Calvez J, Poupin N, Chesneau C, Lassale C, Tomé D.

Eur J Clin Nutr. 2012 Mar;66(3):281-95. doi: 10.1038/ejcn.2011.196. Epub 2011 Nov 30. Review.

PMID:
22127335
[PubMed - indexed for MEDLINE]
8.

Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.

Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K.

Am J Gastroenterol. 2011 Jul;106(7):1209-18; quiz 1219. doi: 10.1038/ajg.2011.113. Epub 2011 Apr 12. Review.

PMID:
21483462
[PubMed - indexed for MEDLINE]
9.

Calcium citrate and vitamin D in the treatment of osteoporosis.

Quesada Gómez JM, Blanch Rubió J, Díaz Curiel M, Díez Pérez A.

Clin Drug Investig. 2011;31(5):285-98. doi: 10.2165/11584940-000000000-00000. Review.

PMID:
21405146
[PubMed - indexed for MEDLINE]
10.

Proton pump inhibitor use and the antifracture efficacy of alendronate.

Abrahamsen B, Eiken P, Eastell R.

Arch Intern Med. 2011 Jun 13;171(11):998-1004. doi: 10.1001/archinternmed.2011.20. Epub 2011 Feb 14.

PMID:
21321287
[PubMed - indexed for MEDLINE]
11.

An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients.

Sato Y, Iwamoto J, Honda Y.

J Stroke Cerebrovasc Dis. 2011 Jan-Feb;20(1):41-6. doi: 10.1016/j.jstrokecerebrovasdis.2009.10.007. Epub 2010 Jul 3.

PMID:
20598577
[PubMed - indexed for MEDLINE]
12.

Bone fractures after menopause.

ESHRE Capri Workshop Group.

Hum Reprod Update. 2010 Nov-Dec;16(6):761-73. doi: 10.1093/humupd/dmq008. Epub 2010 Apr 28. Review.

PMID:
20427370
[PubMed - indexed for MEDLINE]
Free Article
13.

Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.

Fournier MR, Targownik LE, Leslie WD.

Maturitas. 2009 Sep 20;64(1):9-13. doi: 10.1016/j.maturitas.2009.07.006. Epub 2009 Aug 11. Review.

PMID:
19674854
[PubMed - indexed for MEDLINE]
14.

Proton pump inhibitors and bone fractures?

Laine L.

Am J Gastroenterol. 2009 Mar;104 Suppl 2:S21-6. doi: 10.1038/ajg.2009.48. Review.

PMID:
19262543
[PubMed - indexed for MEDLINE]
15.

The effect of proton pump-inhibiting drugs on mineral metabolism.

Insogna KL.

Am J Gastroenterol. 2009 Mar;104 Suppl 2:S2-4. doi: 10.1038/ajg.2009.44. Review.

PMID:
19262542
[PubMed - indexed for MEDLINE]
16.

Potential of alfacalcidol for reducing increased risk of falls and fractures.

Ringe JD, Schacht E.

Rheumatol Int. 2009 Aug;29(10):1177-85. doi: 10.1007/s00296-008-0835-x. Epub 2009 Jan 22.

PMID:
19159932
[PubMed - indexed for MEDLINE]
17.

Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.

Moayyedi P, Cranney A.

Am J Gastroenterol. 2008 Oct;103(10):2428-31. doi: 10.1111/j.1572-0241.2008.02031.x. Review.

PMID:
18855852
[PubMed - indexed for MEDLINE]
18.

[Evidence for efficacy of active vitamin D3 as an anti-osteoporotic drug].

Inoue D.

Clin Calcium. 2008 Oct;18(10):1469-75. doi: CliCa081014691475. Review. Japanese.

PMID:
18830044
[PubMed - indexed for MEDLINE]
19.

Proton pump inhibitor therapy and osteoporosis.

Yang YX.

Curr Drug Saf. 2008 Sep;3(3):204-9. Review.

PMID:
18691003
[PubMed - indexed for MEDLINE]
20.

Proton pump-inhibiting drugs, calcium homeostasis, and bone health.

Wright MJ, Proctor DD, Insogna KL, Kerstetter JE.

Nutr Rev. 2008 Feb;66(2):103-8. doi: 10.1111/j.1753-4887.2008.00015.x. Review.

PMID:
18254877
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk